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Abstract 
Although persistent inflammation has been related to unsuccessful aging, a pro-
inflammatory status is the common phenotype in older people. To assess for a 
genetic component in the inflammatory status of the oldest we studied the 
distribution of two polymorphic chemokine pathway genes, RANTES and CCR5, 
in elderly. RANTES -403G/A and RANTES Int1.1T/C polymorphisms and 
CCR5Δ32 polymorphism were genotyped in 104 elderly and 110 controls. 
RANTES -403A and RANTES Int1.1C alleles have been associated with pro-
inflammatory and anti-inflammatory status, respectively. CCR5∆32 abrogates 
functional receptor expression of the pro-inflammatory CCR5-mediated action. 
Prevalence of RANTES -403G allele, associated in other studies with high 
RANTES production, was reduced in elderly males, compared with controls. In 
addition, RANTES pro-inflammatory haplotype -403A-Int1.1T was 
overrepresented in elderly males, while RANTES anti-inflammatory haplotype -
403G-Int1.1C was overrepresented in elderly females. Our results suggest a 
sex-specific RANTES inflammatory genetic determinant that could contribute to 
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Introduction 
The immune system’s positive protective effect against pathogens and the 
spread of tumour cells can also become a detrimental chronic inflammation 
affecting longevity. Studies on the genetic component of longevity have tended 
to evaluate the role of the immune system genes, especially those involved in 
inflammation. Results obtained reveal that persistent activation of inflammatory 
status is related to unsuccessful aging and that avoiding a persistent 
inflammation contributes to healthy aging. However, a pro-inflammatory status 
is the common phenotype in older people [1].  
Inflammatory response could be affected by changes in chemokine gene 
transcription and receptor expression levels due to polymorphisms at the 
corresponding genes. Previous studies of chemokine factors related to age-
related disease and longevity revealed attrition or change in frequency of 
chemokine alleles with ageing [2, 3]. Chemokines are small chemotactic 
cytokines (C-C) with a pivotal role in leukocyte trafficking and activation. Their 
biological effects are exerted via interaction with G protein-coupled receptors 
that mediate intracellular signals. C-C chemokine receptor type 5 (CCR5) is the 
co-receptor for macrophages and dual (T cell and macrophage) tropic 
immunodeficiency viruses and is involved in the migration of monocytes, NK 
cells and Th1 cells toward an increasing concentration of β-chemokines, which 
results in recruitment of leukocytes to the inflammation site. Natural CCR5 
ligands are the C-C motif chemokine ligands CCL3, CCL4 and CCL5, which is 
also known as RANTES (regulated upon activation normal T-cell expressed and 
secreted). Two polymorphisms have been described in the RANTES gene, a 
promoter polymorphism (-403G/A, rs2107538) whose -403A allele increases the 
promoter transcriptional activity, which results in high serum RANTES levels 
favouring a pro-inflammatory status [4], and an intronic polymorphism 
(Int1.1T/C, rs2280789) whose Int1.1C variant has been associated with low 
RANTES expression and an anti-inflammatory status [5]. A 32pb 
insertion/deletion polymorphism has been described in exon 3 of the CCR5 
gene (CCR5Δ32, rs333) that abrogates functional CCR5 receptor expression, 
weakening the pro-inflammatory CCR5-mediated action [6]. The CCR5Δ32 
allele reaches appreciable frequencies only in Europe, following a latitudinal 
cline distribution that is higher in the north and lower in the south. Studies have 
demonstrated that the CCR5Δ32 allele is related to reduction of portal 
inflammation during hepatitis C (HCV) infection, delayed progression in multiple 
sclerosis, protection against cardiovascular diseases (acute myocardial 
infarction and severe coronary heart disease), and attenuation of the 
inflammatory response that delays progression of atherosclerotic lesions [7]. 
To assess the possibility of a genetic component of inflammatory status in the 
elderly, we studied the distribution of functional polymorphic variants of two 
genes from the chemokine inflammatory pathway, RANTES and CCR5, in long-
lived individuals.  
Methods 
RANTES -403G/A and Int1.1T/C and CCR5Δ32 polymorphisms were 
genotyped by standard procedures (Supplementary Table 1) in a cohort of 214 
subjects. A detailed description of cohorts can be found in [8], briefly: 110 sex-
matched healthy young individuals as a control group, 75 women (mean age 
285.8; range 17-39) and 35 men (mean age 298.6; range 17-40), and 104 
elderly subjects (>85 years), 72 women (mean age 89.43.6; range 85-100) 
and 32 men (mean age 89.43.2; range 85-97). Subjects were enrolled from the 
city of Lleida in northeast Spain, between January and June 2004. Elderly 
subjects were recruited from attendants to Primary Care Services (25%) and 
Nursing Home residents (75%). A comprehensive medical history was obtained 
from each elderly subject. Most frequent co-morbidities were hypertension 
(9.6%), stroke (7.7%), chronic obstructive pulmonary disease (4.8%) and heart 
disease (2.9%). A written informed consent for enrolling in the study and for 
personal data management was obtained from all subjects (elderly and 
controls) in accordance with Spanish laws. The Ethics Committee of our 
institution approved the study. 
Results & Discussion 
Genotype and allele distributions of RANTES -403G/A and CCR5Δ32 
polymorphisms conform to Hardy-Weinberg equilibrium in both the control and 
elderly cohorts. In contrast, RANTES Int1.1T/C departs from Hardy-Weinberg 
equilibrium in the elderly cohort. Comparisons of genotype and allele 
distributions between controls and elderly were done by contingency table 
analysis performed by the OpenEpi web resource 
(http://www.openepi.com/OE2.3/Menu/OpenEpiMenu.htm). Differences were 
evaluated considering all subjects and by sex between cohorts. For 
comparisons including zero values, odds ratio and 95%CI were calculated 
based on the Peto odds ratio method by using the on-line calculator 
http://www.hutchon.net/ConfidORnulhypo.htm. This approach has the 
advantage of accepting zero results without generating infinity. P values <0.05 
were considered statistically significant. In addition, a modified Bonferroni-
corrected nominal threshold of P = 0.05/N was used, where N is the “effective 
number of independent marker loci” after consideration of linkage disequilibrium 
between markers. N was calculated using the SNP (single nucleotide 
polymorphism) spectral decomposition approach web-based program SNPSpD 
(http://gump.qimr.edu.au/general/daleN/SNPSpD/). This yields an experiment-
wide significance threshold of 0.02 to keep Type I error rate at 5%.  
Genotype distribution differences between elderly and controls showed 
statistical significance for Int1.1T/C polymorphism (P=0.03), but not for 
CCR5Δ32 or -403G/A polymorphisms (Table 1). Sex-based differences 
between cohorts for the CCR5Δ32 polymorphism were not significant. 
Nevertheless, differences between elderly and control males were observed for 
the -403G/A genotype (P=0.029) and allele distribution (OR=3.2; 95%CI=1.2-
8.5; P=0.012) (Table 1).  In addition, differences were observed when -403A 
allele was modelled as dominant  (OR=4; 95%CI=1.4-11.8; P=0.01). We also 
found a genotype association for Int1.1C allele under recessive model (Peto 
OR=8.8; 95%CI=1.7-44.7; P=0.008) that was mainly contributed by differences 
between elderly and control females (Peto OR=8.4; 95%CI=1.4-49.9; P=0.02). 
Haplotypes for RANTES gene markers were inferred by pLink software (pLink 
web resource available at http://pngu.mgh.harvard.edu/~purcell/plink/). 
Haplotype distribution between elderly and controls in all subjects, males and 
females, showed significant differences (Omnibus test P=0.02, P=0.05 and 
P=0.04, respectively) (Table 1).  
According to the inflammation-linked effect attributed to both RANTES -403G/A 
and Int1.1T/C polymorphisms, we can presume an anti-inflammatory effect for 
the -403G-Int1.1C (GC) haplotype and the opposite pro-inflammatory effect for 
the -403A-Int1.1T (AT) haplotype. Haplotype-specific test showed that anti-
inflammatory GC haplotype was overrepresented in the elderly cohort (P=0.04), 
mainly due to the overrepresentation in females (Peto OR=8.3; 95%CI=2-34; 
P=0.005). In contrast, pro-inflammatory AT haplotype was overrepresented in 
elderly males (OR=4.9; 95%CI=0.97-24.7; P=0.03).  
Carrier distribution in males and females of pro- and anti-inflammatory 
haplotypes is shown in Figure 1. As revealed by haplotype-specific test, elderly 
males were carriers of the pro-inflammatory AT haplotype, which was more 
prevalent in elderly than in controls (26% and 6%, respectively; OR= 5.6; 
95%CI=1.06-29.7; P=0.038), while carriers of the AT haplotype were equally 
distributed in elderly and control females (10% and 13%, respectively). In 
contrast, elderly females were carriers of the anti-inflammatory GC haplotype 
that was absent in control females (11.4% vs. 0%, respectively; Peto OR= 8.8; 
95%CI=2.1-36.5; P=0.0024). 
Our genetic study of Spanish elderly does not reveal any significant association 
between the CCR5Δ32 polymorphism and longevity. The role of CCR5 in age-
related diseases has been largely reviewed [9]. Assuming the hypothesis that 
alleles favouring inflammation-related diseases are detrimental for longevity and 
considering the inflammatory CCR5-mediated action, we could expect an 
increased prevalence of defective CCR5Δ32 alleles, as well as CCR5Δ32 
carriers, in long-lived individuals. The CCR5Δ32 polymorphism has been 
studied in relation to diseases reducing life expectancy, such as acute 
myocardial infarction and prostate cancer using centenarians as the reference 
population [10,11]. An overrepresentation of the CCR5Δ32 allele was reported 
in centenarians compared to cases, assigning to this polymorphism a role in 
promoting longevity. In these studies the comparison of extreme phenotype 
populations (centenarians vs. affected cases) probably confers an increased 
power to detect association. However, the CCR5Δ32 prevalence in 
centenarians does not differ from that observed in the healthy control population 
which agrees with results obtained in our study. This could reflect a weak 
association of CCR5 with longevity that needs a more highly powered test to be 
established.  
The association of RANTES polymorphisms with longevity has not yet been 
described. Our results denote a sex-specific association with functional 
RANTES polymorphisms. Pro-inflammatory RANTES alleles/haplotypes were 
positively associated with elderly males. In contrast, anti-inflammatory RANTES 
alleles/haplotypes showed positive association with elderly females.  
Elevation of circulating levels of RANTES has been described in unstable 
angina pectoris patients as predictive of future cardiovascular adverse events 
[9]. Furthermore, a significant elevation of major C-C chemokines, including 
RANTES, has been described during the course of acute myocardial infarction 
that actively contributes to the pathophysiology of the disease. Finally, 
association studies of functional RANTES polymorphisms have been performed 
highlighting the role of RANTES in age-related diseases [4]. 
Our findings on RANTES allele/haplotype distribution among elderly suggest a 
RANTES genetic determinant that is prone to a pro-inflammatory phenotype in 
males and an anti-inflammatory phenotype in females, which could contribute to 
the known sex-specific differences in aging. Sexual dimorphism in immune 
responsiveness has been reported with respect to genetic background. Some 
evidence of an increase in frequency of the IL-10 anti-inflammatory cytokine 
gene in long-lived males has been reported [12] and early work suggested that 
sexual dimorphism existed in immune responsiveness in the HLA supratype 
A1B8Cw7DR3 [13]. 
It has been previously described that the inflammation index, calculated as the 
sum of positive indicators such as C-reactive protein, plasma fibrinogen and 
urinary albumin, shows sex differences and varies with age [14]. Women have a 
higher inflammation index during all life stages compared with men but slower 
rates of increase in inflammation with age. This can contribute to the decrease 
in the inflammation differences between the sexes in the elderly population (>80 
year-old) [14].   
Moreover, it has been suggested that the female sex hormone estrogen may 
increase the expression of antioxidant enzymes, playing a protective role that 
improves host resistance to degenerative diseases, and may reduce the risk of 
cardiovascular diseases (CVD) by modulation of fibrinolytic factors [15]. 
Therefore, women have a greater capacity to recover from an inflammatory 
status, probably due to better regulation of the inflammatory response, which, 
as our data points out, can be enabled by the genetic component. The better 
control of inflammation in elderly women might be linked to the higher life 
expectancy. 
We acknowledge that our study have a number of potential limitations. The 
relatively small number of subjects in the elderly cohort, due to the difficulty to 
find older subjects fitting our inclusion criteria, could be considered as an 
important limitation of the study. Some statistical outcomes are based in 
comparisons performed with small numbers or zero subjects that do not pass 
statistical threshold when corrected for multiple testing. Despite having used 
appropriated statistical methods (i.e. Peto odds ratio and Bonferroni-corrected 
SNP spectral decomposition approach) revealing significant results, the 
mentioned limitations require us to consider conclusions as suggestive rather 
than a clear finding.  
The role of sex differences in age trajectories is still unresolved. Our data shows 
that the RANTES genetic component differs between males and females and 
could contribute to their differences in aging trajectories. The appropriate 
regulation of the inflammatory response by a proper balance of pro- and anti-
inflammatory cytokines could be an important factor in reaching extreme 
longevity. Assuming all the limitations previously mentioned our results 
encourage further studies to replicate our findings and to search for additional 
inflammation-related genes that could define an inflammation-related genetic 
component contributing to sex differences in longevity. 
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Figure 1.- Prevalence of carriers of RANTES anti-inflammatory -403G-Int1.1C 
(GC) and pro-inflammatory -403A-Int1.1T (AT) haplotypes between elderly  and 
controls in males (left) and females (right). The numbers within each haplotype 




Table 1. Allele, genotype and haplotype distribution of CCR5Δ32, RANTES -403G/A and RANTES Int1.1T/C 
polymorphisms in Spanish controls and elderly subjects. 




  Controls  Elderly 
 
All subjects   










All subjects   









rs333, (CCR5Δ32)             
Genotypes wtwt  88 (80)  29 (82.9)  59 (78.7)  79 (76)  22 (68.8)  57 (79.2) 
 wtΔ32  22 (20)  6 (17.1)  16 (21.3)  21 (20.2)  9 (28.1)  12 (16.7) 
 Δ32Δ32  0 (0)  0 (0)  0 (0)  3 (2.9)  1 (3.1)  2 (2.8) 
              
 Alleles wt  198 (90)  64 (91.4)  134 (89.3)  179 (86.1)  53 (82.8)  126 (87.5) 
 Δ32  22 (10)  6 (8.6)  16 (10.7)  27 (13)  11 (17.2)  16 (11.1) 
              
rs2107538 (RANTES-403G/A)              
Genotypes GG   75 (68.2)   28 (80)   47 (62.7)   66 (63.5)   16 (50)
a
   50 (69.4) 
 GA   34 (30.9)   7 (20)   27 (36)   35 (33.7)   15 (46.8)   20 (27.8) 
 AA   1 (0.9)   0 (0)   1 (1.3)   3 (2.9)   1 (3.1)   2 (2.8) 
              
 A carriers  35 (31.8)  7(20)  28 (37.3)  38 (36.6)  16 (49.9)
a
  22 (30.6) 
              
 Alleles G   184 (83.6)   63 (90)   121 (80.7)   167 (80.3)   47 (73.4)
a
   120 (83.3) 
  A   36 (16.4)   7 (10)   29 (19.3)   41 (19.7)   17 (26.6)   24 (16.7) 
              
rs2280789 (RANTES Int1.1T/C)                          
Genotypes TT   86 (78.9)   29 (85.3)   57 (76)   71 (73.2)
b
   21 (77.8)   50 (71.4) 
  TC   23 (21.1)   5 (14.7)   18 (24)   20 (20.6)   5 (18.5)   15 (21.4) 
  CC   0 (0)   0 (0)   0 (0)   6 (6.2)
b
   1 (3.7)   5 (7.2)
b
 
              
 Alleles T   195 (89.5)   63 (92.7)   132 (88)   162 (83.5)   47 (87)   115 (82.1) 
  C   23 (10.5)   5 (7.3)   18 (12)   32 (16.5)   7 (13)   25 (17.9) 
              
rs2107538 & rs2280789 (RANTES haplotype) 
c
           
Haplotype counts             
 GT  182 (83.3)  61 (89.6)  121 (80.5)  148 (76.2)  40 (74)
d
  108 (77) 
 AC  23 (10.4)  5 (7.3)  18 (11.9)  24 (12.3)  7 (12.9)  17 (12.1) 
 AT  13 (6.1)  2 (3.1)  11 (7.6)  14 (7.3)  7 (13.1)
e
  7 (5.1) 
 GC  0 (0)  0 (0)  0 (0)  8 (4.2)
f
  0 (0)  8 (5.8)
f
 
              
 
a
 Statistical differences between elderly and control males for global genotype distribution (P=0.029);  RANTES-403A modelled as dominant (Odds 
Ratio (OR)=4.0; 95% confidence interval (CI)=1.4-11.8; P=0.01) and allele distribution (OR= 3.2; 95%CI=1.2-8.5; P=0.014). 
b
 Statistical differences between elderly and controls for global genotype distribution (P=0.03) and RANTES Int1.1C under recessive model (Peto 
OR=8.8; 95%CI=1.7-44.7; P=0.008), mainly attributable to an overrepresentation in females (Peto OR=8.4;  95%CI=1.4-49.9; P=0.02). 
c
 Statistical differences between elderly and controls for global haplotype distribution for all subjects (P=0.02), males (P=0.05) and females (P=0.04). 
d
 GT haplotype was underrepresented in elderly males (OR=0.3; 95%CI=0.12-0.88; P=0.02). 
e
 AT haplotype was overrepresented in elderly males (OR=4.9; 95%CI=0.97-24.7; P=0.03). 
f
 GC haplotype was overrepresented in elderly subjects (P=0.04) due to the overrepresentation in females (Peto OR=8.3; 95%CI=2-34; P=0.005)  
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